Gilead Sciences agrees to acquire biotech company Arcellx for $7.8 billion.
February 23, 2026 - 15:47
By Pharos Investment Advisors Comments are Off
Gilead Sciences agrees to acquire biotech company Arcellx for $7.8 billion.
Regulated by Hellenic Capital Market Commission
with Registration Number 5/700/10.12.2014

Copyright 2023©. All Rights Reserved